Stock Analysis: PharmaEssentia

Company: PharmaEssentia Corporation

Bloomberg ticker: 6446 TT

Market cap: US$6,191m

Background: PharmaEssentia Corporation develops and distributes drugs to treat hepatitis, chronic myeloid leukemia, essential thrombocythemia, myeloid fibrosis, polycythemia vera, hepatitis, and cancer. The company was founded in 2003 by a group of Taiwanese-American executives and scientists from American biotech and pharmaceutical companies.
 

World Class Benchmarking of PharmaEssentia Corp
 

(Click on image to enlarge)

 

• Profitable Growth rank of 1 was same compared to the prior period’s 1st rank
• This is World Class performance compared to 310 medium Health Care companies worldwide
• Profitability rank of 1 was the same as its Growth rank of 1
• Profitability rank of 1 was up compared to the prior period’s 3rd rank
• This is World Class performance compared to peers
• Growth rank of 1 was the same compared to the prior period’s 1st rank
• This is World Class performance compared to peers

---

More By This Author:

Stock Analysis: MeiHua Holdings Group
Stock Analysis: Bukalapak.com
Stock Analysis: Siam Cement